AU2003226567A1 - Particulate materials - Google Patents

Particulate materials

Info

Publication number
AU2003226567A1
AU2003226567A1 AU2003226567A AU2003226567A AU2003226567A1 AU 2003226567 A1 AU2003226567 A1 AU 2003226567A1 AU 2003226567 A AU2003226567 A AU 2003226567A AU 2003226567 A AU2003226567 A AU 2003226567A AU 2003226567 A1 AU2003226567 A1 AU 2003226567A1
Authority
AU
Australia
Prior art keywords
particulate materials
particulate
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003226567A
Inventor
Jane Catherine Feeley
Mahboob Ur Rehman
Boris Yu Shekunov
Peter York
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nektar Therapeutics UK Ltd
Original Assignee
Nektar Therapeutics UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0209402A external-priority patent/GB0209402D0/en
Priority claimed from GB0210268A external-priority patent/GB0210268D0/en
Priority claimed from GB0211086A external-priority patent/GB0211086D0/en
Priority claimed from GBGB0216562.9A external-priority patent/GB0216562D0/en
Application filed by Nektar Therapeutics UK Ltd filed Critical Nektar Therapeutics UK Ltd
Publication of AU2003226567A1 publication Critical patent/AU2003226567A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003226567A 2002-04-25 2003-04-24 Particulate materials Abandoned AU2003226567A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
GB0209402.7 2002-04-23
GB0209402A GB0209402D0 (en) 2002-04-25 2002-04-25 Particulate materials
GB0210174A GB0210174D0 (en) 2002-04-25 2002-05-03 Particulate materials
GB0210174.9 2002-05-03
GB0210268A GB0210268D0 (en) 2002-04-25 2002-05-07 Particulate materials
GB0210268.9 2002-05-07
GB0211086.4 2002-05-15
GB0211086A GB0211086D0 (en) 2002-04-25 2002-05-15 Particulate materials
GBGB0216562.9A GB0216562D0 (en) 2002-04-25 2002-07-17 Particulate materials
GB0216562.9 2002-07-17
PCT/GB2003/001747 WO2003090715A2 (en) 2002-04-25 2003-04-24 Particulate materials

Publications (1)

Publication Number Publication Date
AU2003226567A1 true AU2003226567A1 (en) 2003-11-10

Family

ID=28795261

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003226567A Abandoned AU2003226567A1 (en) 2002-04-25 2003-04-24 Particulate materials

Country Status (5)

Country Link
EP (1) EP1501483A2 (en)
AU (1) AU2003226567A1 (en)
CA (1) CA2483218C (en)
GB (1) GB2387781A (en)
WO (1) WO2003090715A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0407368A (en) * 2003-02-10 2006-02-14 Bayer Healthcare Ag treatment of bacterial diseases of the respiratory organs by local application and fluorquinolones.
US9061027B2 (en) 2004-08-27 2015-06-23 Board Of Regents, The University Of Texas System Enhanced delivery of drug compositions to treat life threatening infections
DK2252275T3 (en) * 2008-02-13 2018-03-05 Univ Texas CREATED NON-OPEN FLOCKS OF ANISOTROPIC PARTICLES FOR IMPROVED TRANSPORT INTO THE Lungs
GB0921481D0 (en) * 2009-12-08 2010-01-20 Vectura Ltd Process and product
WO2014186754A2 (en) 2013-05-16 2014-11-20 Board Of Regents The University Of Texas System Dry solid aluminum adjuvant-containing vaccines and related methods thereof
SG11201608985QA (en) 2014-04-28 2016-11-29 Philip Morris Products Sa Flavoured nicotine powder inhaler
HUE045841T2 (en) * 2014-04-28 2020-01-28 Philip Morris Products Sa Nicotine powder inhaler
JP6921759B2 (en) 2015-06-04 2021-08-18 クリティテック・インコーポレイテッド Collection device and usage
AU2017246316B2 (en) 2016-04-04 2022-09-29 Crititech, Inc. Methods for solid tumor treatment
SG11201909840TA (en) 2017-06-09 2019-11-28 Crititech Inc Treatment of epithelial cysts by intracystic injection of antineoplastic particles
CA3063436A1 (en) 2017-06-14 2018-12-20 Crititech, Inc. Methods for treating lung disorders
CA3076919A1 (en) 2017-10-03 2019-04-11 Crititech, Inc. Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
US11918646B2 (en) 2017-12-11 2024-03-05 Board Of Regents, The University Of Texas System Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
GB9313650D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
GB9703673D0 (en) * 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
DE10129374A1 (en) * 2001-06-20 2003-01-02 Roehm Gmbh Process for the production of moldings with electrically conductive coating and moldings with appropriate coating

Also Published As

Publication number Publication date
CA2483218A1 (en) 2003-11-06
WO2003090715A2 (en) 2003-11-06
CA2483218C (en) 2012-07-10
GB2387781A8 (en) 2003-12-17
WO2003090715A3 (en) 2004-03-11
EP1501483A2 (en) 2005-02-02
GB2387781A (en) 2003-10-29

Similar Documents

Publication Publication Date Title
AU2003293294A1 (en) Uv-stabilised particles
AU2003280351A1 (en) Pulverulent materials
AU2003268291A1 (en) Indefinite materials
GB2401547B (en) Particulate materials
AU2002367404A1 (en) Redox-switchable materials
AU2003281851A1 (en) Photoactive materials
AU2003225901A1 (en) Stabilized inorganic particles
AUPS160702A0 (en) Particulate matter conveyor
GB0216562D0 (en) Particulate materials
AU2003226567A1 (en) Particulate materials
GB0524716D0 (en) Particulate materials
AU2003249304A1 (en) Superabsorbent materials
AU2003245092A1 (en) Sound-absorbing material
AU2002315564A1 (en) Particulate material dispenser
AU2003229087A1 (en) Single-crystal-like materials
GB0329208D0 (en) Particulate materials
AU2003252969A1 (en) Depositing solid materials
AU2003278334A1 (en) Material
AU2002950855A0 (en) Materials
AU2003282501A1 (en) Three component filtration material
AU2003290166A1 (en) Materials handling aid
GB2405334B (en) Particulate materials
GB0209204D0 (en) Particulate materials
GB0211086D0 (en) Particulate materials
GB0210174D0 (en) Particulate materials

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase